US 8,629,302 · Application 13/496,340 · Granted Jan 14, 2014
US 8,629,302
Methods for preparing hypericin
Estimated expiration
September 15, 2030
3y 354d remaining
Earliest effective filing
Sep 15, 2010
+ 20 years
Sep 15, 2030
PTA +0d
Sep 15, 2030
No TD
—
Final
Sep 15, 2030
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- June 4, 2012
- Earliest effective filing
- September 15, 2010
- Issue date
- January 14, 2014
- PTA
- 0 days
- Base expiry (before PTA)
- September 15, 2030
September 15, 2010 + 20 years = September 15, 2030
- National stage entry of application PCTUS2010048937, filed Sep 15, 2010
- PRO61/242,492 — Provisional — not used for base term
- PRO61/242,492 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 13/496,340 · US 8,629,302
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 8,629,302: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US8629302Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.